Literature DB >> 16937330

Pulmonary hypertension after liver transplantation in patients with antecedent hepatopulmonary syndrome: a report of 2 cases and review of the literature.

Federico Aucejo1, Charles Miller, David Vogt, Bijan Eghtesad, Shunichi Nakagawa, James K Stoller.   

Abstract

Hepatopulmonary syndrome (HPS) and portopulmonary hypertension (PPHTN) are distinct clinical entities that may complicate liver disease. Although HPS and PPHTN are different, several reports describe 6 patients in whom both conditions have occurred, either concurrently or sequentially, sometimes with the onset of PPHTN after liver transplantation. The current report extends this sparse experience by reporting 2 patients who underwent liver transplantation for HPS and who developed pulmonary hypertension after liver transplantation. This experience calls for better understanding of the pathogenesis of HPS and PPHTN and ways to better predict their occurrence. (c) 2006 AASLD.

Entities:  

Mesh:

Year:  2006        PMID: 16937330     DOI: 10.1002/lt.20830

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  12 in total

1.  Acute right ventricular failure after orthotopic liver transplantation.

Authors:  Rohan M Goswami; Rami N Khouzam
Journal:  Ann Transl Med       Date:  2018-01

Review 2.  Hepatopulmonary Syndrome and Portopulmonary Hypertension: The Pulmonary Vascular Enigmas of Liver Disease.

Authors:  Michael J Krowka
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-03-02

3.  Living donor liver transplantation for end-stage liver disease with severe hepatopulmonary syndrome: report of a case.

Authors:  Takashi Motomura; Toru Ikegami; Yohei Mano; Shigeyuki Nagata; Keishi Sugimachi; Tomoharu Gion; Yuji Soejima; Akinobu Taketomi; Ken Shirabe; Yoshihiko Maehara
Journal:  Surg Today       Date:  2011-03-02       Impact factor: 2.549

4.  A central role for CD68(+) macrophages in hepatopulmonary syndrome. Reversal by macrophage depletion.

Authors:  Thenappan Thenappan; Ankush Goel; Glenn Marsboom; Yong-Hu Fang; Peter T Toth; Hannah J Zhang; Hidemi Kajimoto; Zhigang Hong; Jonathan Paul; Christian Wietholt; Jennifer Pogoriler; Lin Piao; Jalees Rehman; Stephen L Archer
Journal:  Am J Respir Crit Care Med       Date:  2010-12-10       Impact factor: 21.405

Review 5.  Hepatopulmonary syndrome: update on pathogenesis and clinical features.

Authors:  Junlan Zhang; Michael B Fallon
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-07-03       Impact factor: 46.802

6.  Hepatopulmonary Syndrome and Portopulmonary Hypertension: Current Status and Implications for Liver Transplantation.

Authors:  Kelley Weinfurtner; Kimberly Forde
Journal:  Curr Hepatol Rep       Date:  2020-07-11

Review 7.  Pulmonary vascular complications of liver disease.

Authors:  Jason S Fritz; Michael B Fallon; Steven M Kawut
Journal:  Am J Respir Crit Care Med       Date:  2012-11-15       Impact factor: 21.405

8.  Venous outflow obstruction and portopulmonary hypertension after orthotopic liver transplantation.

Authors:  Guadalupe Aguirre-Avalos; Marco Antonio Covarrubias-Velasco; Antonio Gerardo Rojas-Sánchez
Journal:  Am J Case Rep       Date:  2013-09-09

9.  Low serum levels of alpha1 anti-trypsin (α1-AT) and risk of airflow obstruction in non-primary α1-AT-deficient patients with compensated chronic liver disease.

Authors:  Elizabeth Rodríguez-Romero; Juan Antonio Suárez-Cuenca; César Iván Elizalde-Barrera; Paul Mondragón-Terán; José Enrique Martínez-Hernández; Eduardo Gómez-Cortés; Rebeca Pérez-Cabeza de Vaca; Rolando E Hernández-Muñoz; Alberto Melchor-López; Nayeli Gabriela Jiménez-Saab
Journal:  Med Sci Monit       Date:  2015-04-27

10.  Transition from hepatopulmonary syndrome to portopulmonary hypertension: a case series of 3 patients.

Authors:  Radhika Zopey; Irawan Susanto; Igor Barjaktarevic; Tisha Wang
Journal:  Case Rep Pulmonol       Date:  2013-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.